SG11202106061VA - Dna polymerase iiic inhibitors and use thereof - Google Patents
Dna polymerase iiic inhibitors and use thereofInfo
- Publication number
- SG11202106061VA SG11202106061VA SG11202106061VA SG11202106061VA SG11202106061VA SG 11202106061V A SG11202106061V A SG 11202106061VA SG 11202106061V A SG11202106061V A SG 11202106061VA SG 11202106061V A SG11202106061V A SG 11202106061VA SG 11202106061V A SG11202106061V A SG 11202106061VA
- Authority
- SG
- Singapore
- Prior art keywords
- dna polymerase
- inhibitors
- polymerase iiic
- iiic inhibitors
- dna
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862783754P | 2018-12-21 | 2018-12-21 | |
PCT/US2019/067351 WO2020132174A1 (en) | 2018-12-21 | 2019-12-19 | Dna polymerase iiic inhibitors and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202106061VA true SG11202106061VA (en) | 2021-07-29 |
Family
ID=71100345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202106061VA SG11202106061VA (en) | 2018-12-21 | 2019-12-19 | Dna polymerase iiic inhibitors and use thereof |
Country Status (11)
Country | Link |
---|---|
US (5) | US10723741B1 (he) |
EP (1) | EP3897645A4 (he) |
JP (1) | JP2022515775A (he) |
KR (1) | KR20210106508A (he) |
CN (1) | CN113507929A (he) |
AU (1) | AU2019404179A1 (he) |
CA (1) | CA3123843A1 (he) |
IL (1) | IL283684B2 (he) |
MX (1) | MX2021007219A (he) |
SG (1) | SG11202106061VA (he) |
WO (1) | WO2020132174A1 (he) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1212201A (en) * | 1999-10-21 | 2001-04-30 | Merck & Co., Inc. | Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment |
AU2003210958A1 (en) | 2002-02-08 | 2003-09-02 | Glsynthesis Inc. | Purine and isosteric antibacterial compounds |
WO2005040163A1 (en) | 2003-10-28 | 2005-05-06 | Dr. Reddy's Laboratories Ltd | Heterocyclic compounds that block the effects of advanced glycation end products (age) |
AU2004286277A1 (en) * | 2003-10-28 | 2005-05-12 | Reddy Us Therapeutics, Inc. | Heterocyclic compounds and methods of making and using thereof |
WO2008011191A1 (en) | 2006-07-21 | 2008-01-24 | Replidyne, Inc. | Antibacterial heterocyclic ureas |
WO2008071650A2 (en) * | 2006-12-11 | 2008-06-19 | Galapagos N.V. | Novel compounds useful for the treatment of degenerative & inflammatory diseases |
WO2009015193A1 (en) | 2007-07-23 | 2009-01-29 | Replidyne, Inc. | Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds |
EP2475252B1 (en) * | 2009-09-11 | 2016-11-16 | GLSynthesis Inc. | Selective antibacterials for clostridium difficile infections |
AU2013279021C1 (en) | 2012-06-19 | 2017-03-16 | Debiopharm International Sa | Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
KR20180114177A (ko) | 2016-02-26 | 2018-10-17 | 데비오팜 인터네셔날 에스 에이 | 당뇨병성 족부 감염의 치료제 |
FI3923914T3 (fi) | 2019-02-14 | 2023-04-27 | Debiopharm Int Sa | Afabisiiniformulaatio, menetelmä sen valmistamiseksi |
-
2019
- 2019-12-19 EP EP19898867.7A patent/EP3897645A4/en active Pending
- 2019-12-19 AU AU2019404179A patent/AU2019404179A1/en active Pending
- 2019-12-19 JP JP2021536093A patent/JP2022515775A/ja active Pending
- 2019-12-19 CA CA3123843A patent/CA3123843A1/en active Pending
- 2019-12-19 KR KR1020217022548A patent/KR20210106508A/ko unknown
- 2019-12-19 WO PCT/US2019/067351 patent/WO2020132174A1/en unknown
- 2019-12-19 CN CN201980084447.2A patent/CN113507929A/zh active Pending
- 2019-12-19 SG SG11202106061VA patent/SG11202106061VA/en unknown
- 2019-12-19 US US16/720,724 patent/US10723741B1/en active Active
- 2019-12-19 MX MX2021007219A patent/MX2021007219A/es unknown
-
2020
- 2020-06-15 US US16/901,752 patent/US10836772B2/en active Active
- 2020-06-15 US US16/901,598 patent/US11001592B2/en active Active
-
2021
- 2021-04-02 US US17/221,102 patent/US20220112195A1/en not_active Abandoned
- 2021-06-03 IL IL283684A patent/IL283684B2/he unknown
-
2023
- 2023-04-11 US US18/298,449 patent/US20230250102A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN113507929A (zh) | 2021-10-15 |
US20220112195A1 (en) | 2022-04-14 |
IL283684A (he) | 2021-07-29 |
IL283684B (he) | 2022-11-01 |
US20200308179A1 (en) | 2020-10-01 |
US10836772B2 (en) | 2020-11-17 |
KR20210106508A (ko) | 2021-08-30 |
EP3897645A1 (en) | 2021-10-27 |
US11001592B2 (en) | 2021-05-11 |
JP2022515775A (ja) | 2022-02-22 |
MX2021007219A (es) | 2021-09-23 |
US20200308180A1 (en) | 2020-10-01 |
EP3897645A4 (en) | 2022-08-31 |
IL283684B2 (he) | 2023-03-01 |
CA3123843A1 (en) | 2020-06-25 |
AU2019404179A1 (en) | 2021-06-10 |
US10723741B1 (en) | 2020-07-28 |
WO2020132174A1 (en) | 2020-06-25 |
US20230250102A1 (en) | 2023-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL291100A (he) | רפליקון רנ" א עבור ביטוי גן מגוון ויעיל | |
HUE048545T2 (hu) | Duplex rozsdamentes acél és annak felhasználása | |
GB201809634D0 (en) | Photocatalyst and use thereof | |
EP3572400C0 (en) | EZH2 INHIBITOR AND ITS USE | |
HUE063120T2 (hu) | LRRC33-inhibitorok és alkalmazásuk | |
IL274115A (he) | הגן לעמידות לחלדון (WTK1 (Yr15 והשימוש בו | |
IL282350A (he) | מעכבים ברנני-rgmc ושימוש בהם | |
EP3910066A4 (en) | DNA REFERENCE STANDARD AND ITS USE | |
IL279276A (he) | מעכב erk ושימוש בו | |
EP3574097A4 (en) | VIRAL SYNTHETIC NUCLEIC ACID SEQUENCES AND THEIR USES | |
EP3901287A4 (en) | NEW DNA APTAMER AND ITS USE | |
ZA201908276B (en) | Charge-tagged nucleotides and methods of use thereof | |
HK1214623A1 (zh) | 標簽、 引物及其應用 | |
IL283684B (he) | מעכבי פולימראז דנ" א iiic ושימושים שלהם | |
ZA201907988B (en) | Labeled nucleotides and uses thereof | |
IL280408A (he) | מעכבי cdk ושימושים בהם | |
EP3322817B8 (de) | Oligonucleotide und deren verwendung | |
PL3356545T3 (pl) | Stosowanie starterów pcr i sposobów identyfikacji bacillus coagulans | |
EP3231897A4 (en) | Biological metal corrosion inhibitor and use thereof | |
IL266154A (he) | מעכבי דנ" א פרימאז וגיראז | |
GB201908884D0 (en) | Inhibitors and use | |
EP3818170A4 (en) | TEMPERATURE CONTROLLED DNA POLYMERASE INHIBITORS |